<DOC>
	<DOCNO>NCT01972139</DOCNO>
	<brief_summary>An international , multi-center , prospective , blind , randomize , control trial . The objective demonstrate catheter-based renal denervation effective safe treatment uncontrolled hypertension .</brief_summary>
	<brief_title>Renal Denervation Patients With Uncontrolled Hypertension - SYMPLICITY HTN-4</brief_title>
	<detailed_description>After 6 month follow-up required testing complete , control group subject would unblinded randomization group would option , discretion Investigator write concurrence medical monitor , treat renal denervation procedure . However , enrollment closure , subject previously randomize long allow cross-over .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<criteria>Individual maximally tolerate stable medication regimen include 3 antihypertensive medication different class , one must thiazide thiazidelike diuretic Individual office SBP great equal 140mmHg less 160mmHg Individual ABPM average SBP great equal 135 mmHg Individual lack appropriate renal artery anatomy Individual eGFR less 30 Individual Type I diabetes mellitus Individual one episodes orthostatic hypotension Individual require chronic oxygen nocturnal respiratory support sleep apnea Individual primary pulmonary hypertension Individual concomitant condition may adversely affect patient study outcomes Individual pregnant , nurse planning pregnant Individual previous organ transplant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Uncontrolled hypertension</keyword>
	<keyword>blood pressure</keyword>
	<keyword>renal denervation</keyword>
	<keyword>HTN-4</keyword>
	<keyword>SYMPLICITY</keyword>
</DOC>